Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven by Digital Insulin Pens and Pumps Transforming Diabetes Care, Says a 2026 Mordor Intelligence Report ...

The MarketWatch News Department was not involved in the creation of this content. Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital ...

The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, according to an industry press release. The implantable device (Portal ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug ...

Pharmaceutical companies layer on patents for drug delivery devices to maintain market exclusivity, according to a new study.

WASHINGTON -- The U.S. government has cleared the way for the first medical device that enables automated insulin dosing for people with type 2 diabetes. The plastic pod, called the Omnipod 5 ...

The designation supports priority engagement with the FDA as Portal Diabetes advances clinical trials and regulatory submissions.

An innovative insulin implant could redefine the future of diabetes management. Here's how this breakthrough diabetes treatment works, its benefits, risks, and what it means for people living with ...

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

Thousands of diabetic patients are hacking into their insulin pumps to make them automatically estimate blood glucose levels and adjust insulin levels accordingly, Irl Hirsch, MD, a professor at ...